Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
about
Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1Bile acid transportersThe role of inflammation in cholestasis: clinical and basic aspectsHeat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanismsRegulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4alpha and PGC1alpha.Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcersSepsis-associated cholestasis is critically dependent on P-selectin-dependent leukocyte recruitment in mice.Clinical application of transcriptional activators of bile salt transporters.Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.Bile formation and secretion.Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in miceIntertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.Regulation of hepatic ABCC transporters by xenobiotics and in disease states.TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injuryMechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins.Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp geneIL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin.Increased Renal Clearance of Rocuronium Compensates for Chronic Loss of Bile Excretion, via upregulation of Oatp2.Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice.The molecular pathogenesis of cholestasis in sepsisBile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.Cholestatic liver (dys)function during sepsis and other critical illnesses.Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.Liver - guardian, modifier and target of sepsis.Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.Churg-Strauss syndrome manifesting as cholestasis and diagnosed by liver biopsy.Gene silencing of non-obese diabetic receptor family (NLRP3) protects against the sepsis-induced hyper-bile acidaemia in a rat model.Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis.Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the blood-cerebrospinal fluid barrierGene-specific alterations of hepatic gene expression by ligand activation or hepatocyte-selective inhibition of retinoid X receptor-α signalling during inflammation.Effects of fluoroquinolone treatment on MDR1 and MRP2 mRNA expression in Escherichia coli-infected chickens.Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis.Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
P2860
Q24313001-50AB671C-A855-4325-98B8-CCF0EDBBE616Q24652624-E6ACBB5B-614C-46DE-92F5-1B694284A1C1Q27694662-B6441FBE-C1AC-4ECD-99BA-D20D9D841920Q28576055-51604AFA-C2B0-4E5B-B955-C3CF6CDD5D07Q28578667-52DEDF07-F7E5-49C8-8FC4-97869C661252Q28579409-A0350D12-6BA4-4A71-8F7E-464E2F72889AQ30273672-71627044-3537-4BF4-8938-28D39BCE7A36Q30591853-D1CA8D8E-B6EA-41B5-BC1C-446AA24E34F6Q33270438-80BB6ED0-C24A-442A-8858-B62083484C53Q33709930-D814498A-687D-4A18-BD27-9BF558817DA6Q33859400-2B7939EC-3ED5-424F-93F7-4544E457109AQ33881922-705C8E8C-1511-4347-A189-58C71592B5FCQ34089798-06D46255-145D-4D88-8ABF-C7418847EEE9Q34962993-5496C339-0174-4E37-9B03-7AECE717561DQ35690177-399CF1F8-4B1A-4ABC-8636-F18084F04E01Q36387273-EDE2B4FA-2449-4E57-A511-1FFC3A060EC2Q36606886-2AEBCB31-96C3-4ABD-9D61-729D7311074CQ36811310-E1787B89-CAE0-4B19-956D-25DE14DA6639Q36846491-F61CF7E4-6313-48E4-9CDD-FCA3E48FA4DBQ37155289-D2F906C8-04CA-4584-AEFC-E44EDC588244Q37160476-B6B26FE3-0DB8-4C55-835B-F9BDC702C1C0Q37584563-ACA0877A-5EB3-46E9-AB54-9E4C42F2E5D5Q37604385-7AEEFD85-4EC1-44ED-88E6-C26D861752DBQ37673642-7221F8D4-D02F-411C-81C0-100A9265C757Q38070531-6990181E-86EA-42D8-A9B2-FE8B639B4AAEQ38340648-521FB7CA-EA0E-4DFC-8B98-667192C98CD4Q38590747-1EB98BB5-B34A-4DDA-B998-15A52F70BE51Q38711186-4638BB1B-E24E-4E57-AD4C-D7D8677971BBQ38737633-7F6C98F9-A242-4450-92AB-D4A5772D9D49Q39031051-E7794397-3C46-415D-9281-915D4504F19CQ40080714-25432893-73BE-4CD2-8A25-5B8D17FF02E0Q40278003-C79F2B36-AEDE-4EFF-8ACA-BC11C8E53DE4Q41736706-1345E4A6-0610-4766-972E-FB1267632612Q41812163-90B48D4E-2DAB-45BF-ACD5-FEEA3A7038DAQ41941715-693F2BF7-4D98-4D7D-AA9B-7A4ACE7B0394Q41949235-62819D0E-D222-4AEB-B505-B3AC6520D8D4Q42106445-03005D75-E907-4082-87CF-CE758F8F4F9EQ46457836-11C5F2E8-C999-4100-9ACA-F4F5268DFFCAQ49118911-94F49D81-980A-4D1E-807E-231289E2092FQ51829714-4EA621C9-34FB-4110-B776-9DE0CCA47B83
P2860
Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@en
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@nl
type
label
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@en
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@nl
prefLabel
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@en
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@nl
P2093
P2860
P356
P1476
Cytokine-dependent regulation ...... ransactivators in mouse liver.
@en
P2093
Andreas Geier
Anne Schmitz
Carsten Gartung
Christoph G Dietrich
Diana Boraschi
Frank Lammert
Frederick J Suchy
Hermann E Wasmuth
Meenakshisundaram Ananthanarayanan
Michael Trauner
P2860
P304
P356
10.1152/AJPGI.00307.2004
P577
2005-04-28T00:00:00Z